Tags

Type your tag names separated by a space and hit enter

High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
Mov Disord. 1996 May; 11(3):327-9.MD

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Letter
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

8723153

Citation

Facca, A, and J Sanchez-Ramos. "High-dose Pergolide Monotherapy in the Treatment of Severe Levodopa-induced Dyskinesias." Movement Disorders : Official Journal of the Movement Disorder Society, vol. 11, no. 3, 1996, pp. 327-9.
Facca A, Sanchez-Ramos J. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. Mov Disord. 1996;11(3):327-9.
Facca, A., & Sanchez-Ramos, J. (1996). High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. Movement Disorders : Official Journal of the Movement Disorder Society, 11(3), 327-9.
Facca A, Sanchez-Ramos J. High-dose Pergolide Monotherapy in the Treatment of Severe Levodopa-induced Dyskinesias. Mov Disord. 1996;11(3):327-9. PubMed PMID: 8723153.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. AU - Facca,A, AU - Sanchez-Ramos,J, PY - 1996/5/1/pubmed PY - 1996/5/1/medline PY - 1996/5/1/entrez SP - 327 EP - 9 JF - Movement disorders : official journal of the Movement Disorder Society JO - Mov Disord VL - 11 IS - 3 SN - 0885-3185 UR - https://www.unboundmedicine.com/medline/citation/8723153/High_dose_pergolide_monotherapy_in_the_treatment_of_severe_levodopa_induced_dyskinesias_ DB - PRIME DP - Unbound Medicine ER -